Multiple myeloma is a cancer of the bone marrow plasma cells. It is synonymous with "myeloma" and "plasma cell myeloma." Plasma cells make antibodies against infectious agents such as viruses and bacteria. A cancerous or malignant plasma cell is called a myeloma cell. Myeloma is called “multiple” because there are frequently multiple patches or areas in bone marrow where it grows.

As the COVID-19 respiratory virus spreads around the world, please know that the IMF is here for you. Click here for more resources. This page provides updated guidance to keep you safe. Featured are Dr. Durie’s blogs and FAQs, aimed specifically at myeloma patients, and links to the best sources of COVID-19 news.

This week America faced twin crises—a continuing pandemic and massive protests against racial and institutional inequalities. Sadly, COVID-19 is impacting Black Americans disproportionately and the reasons for that are the subject of a congressional briefing today. IMF Chairman Dr. Brian G.M. Durie also spotlights new research examining the coronavirus in people living with myeloma and MGUS. Bottom line: safety measures need to continue.

With the growing concerns over the COVID-19 (coronavirus) outbreak, we want to ensure you have access to our resources. With a focus on the health and well-being of our staff, the IMF’s office will close on Friday, March 13, 2020. However, we are still here for you! Our entire staff will be working from home, and as always, we’re available.

Week in Review by Dr. Brian Durie

Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.